Author | Alan Cohen, MD

Articles

Paclitaxel, UFT, and Calcium Folinate in Metastatic Breast Cancer

July 01, 1999

This is a phase I dose-escalation study of uracil and tegafur (in a molar ratio of 4:1 [UFT]) administered in combination with calcium folinate and paclitaxel in metastatic breast cancer. This trial was initiated to 1)